Supplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance

Supplemental Figure S7 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance

<p>Supplemental Figure S7 shows clone family gene signature set expression at drug tolerance.</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Jennifer L. Cotton (17315204) (author)
Andere auteurs:	Javier Estrada Diez (17315207) (author), Vivek Sagar (17315210) (author), Julie Chen (17315213) (author), Michelle Piquet (15460169) (author), John Alford (17315216) (author), Youngchul Song (17315219) (author), Xiaoyan Li (17315222) (author), Markus Riester (17315225) (author), Matthew T. DiMare (17315228) (author), Katja Schumacher (17315231) (author), Gaylor Boulay (17315234) (author), Kathleen Sprouffske (15099146) (author), Lin Fan (17315237) (author), Tyler Burks (17315240) (author), Leandra Mansur (17315243) (author), Joel Wagner (17315246) (author), Hyo-eun C. Bhang (17315249) (author), Oleg Iartchouk (17315252) (author), John Reece-Hoyes (17315255) (author), Erick J. Morris (17315258) (author), Peter S. Hammerman (17315261) (author), David A. Ruddy (15460166) (author), Joshua M. Korn (17315264) (author), Jeffrey A. Engelman (17315267) (author), Matthew J. Niederst (17315270) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Tumor Biology Therapeutic Research and Development Methods and Technology Drug Resistance Lung Cancer Single Cell Technologies Tumor Heterogeneity
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Supplemental Figure S1 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S2 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S3 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S4 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S5 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S6 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Figure S8 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Supplemental Tables 1 - 12 from Expressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance
door: Jennifer L. Cotton (17315204)
Gepubliceerd in: (2025)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
door: Robert L. Hollis (15034814)
Gepubliceerd in: (2025)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
door: Robert L. Hollis (15034814)
Gepubliceerd in: (2025)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
door: Robert L. Hollis (15034814)
Gepubliceerd in: (2025)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
door: Robert L. Hollis (15034814)
Gepubliceerd in: (2025)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
door: Robert L. Hollis (15034814)
Gepubliceerd in: (2025)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
door: Robert L. Hollis (15034814)
Gepubliceerd in: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S7 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Table S8 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
door: Stéphane Fattori (15048281)
Gepubliceerd in: (2025)

Supplemental Tables 1-8 from Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated <i>SPP1</i><sup>+</sup> Macrophages and Fibroblasts
door: Anuja Sathe (15028097)
Gepubliceerd in: (2025)

Supplemental Table 1 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
door: Morten Lapin (15056728)
Gepubliceerd in: (2025)

Supplemental Table 2 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
door: Morten Lapin (15056728)
Gepubliceerd in: (2025)

Supplemental Table 3 from Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer
door: Morten Lapin (15056728)
Gepubliceerd in: (2025)

Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
door: Yibin Dai (16374331)
Gepubliceerd in: (2025)

Supplementary Table S2 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
door: Yibin Dai (16374331)
Gepubliceerd in: (2025)

Table S1 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
door: Guillaume Davidson (14964069)
Gepubliceerd in: (2025)

Table S2 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
door: Guillaume Davidson (14964069)
Gepubliceerd in: (2025)

Table S3 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
door: Guillaume Davidson (14964069)
Gepubliceerd in: (2025)

Table S4 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
door: Guillaume Davidson (14964069)
Gepubliceerd in: (2025)

Table S9 from Cross-talk between Myeloid and B Cells Shapes the Distinct Microenvironments of Primary and Secondary Liver Cancer
door: Zhihang Chen (17315678)
Gepubliceerd in: (2025)

Supplementary Table1 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
door: Yidan Ren (14845140)
Gepubliceerd in: (2025)

Supplementary Table2 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
door: Yidan Ren (14845140)
Gepubliceerd in: (2025)

Supplementary Table3 from USP48 Stabilizes Gasdermin E to Promote Pyroptosis in Cancer
door: Yidan Ren (14845140)
Gepubliceerd in: (2025)

Suppl video 1 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
door: Andrew O. Yam (15293045)
Gepubliceerd in: (2025)

Suppl video 2 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
door: Andrew O. Yam (15293045)
Gepubliceerd in: (2025)

Suppl video 3 from Neutrophil Conversion to a Tumor-Killing Phenotype Underpins Effective Microbial Therapy
door: Andrew O. Yam (15293045)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_8p7gbqjn3mlb9a5sqjdq2sfcru